ReachMD

Be part of the knowledge.™

Rheumatology

16

LikeLikedUnlike

Episodes 1-15 of 28

Treating Psoriatic Arthritis (PsA) and Ankylosing Spondylitis (AS): A Virtual Simulation
Medical Industry Feature
Treating Psoriatic Arthritis (PsA) and Ankylosing Spondylitis (AS): A Virtual Simulation
- Evan Siegel, MD
  Peer
- Reeti Joshi, MD
  Peer
Breaking Down Barriers for PAH Patient Risk Assessment Through EHR Systems
Medical Industry Feature
Breaking Down Barriers for PAH Patient Risk Assessment Through EHR Systems
- Randy Young, MD
  Peer
- Abhijit Raval, MD
  Peer
- Kelly Dickson, RT
  Peer
The First Biologic Approved to Treat PMR: A Clinical Deep Dive
Medical Industry Feature
The First Biologic Approved to Treat PMR: A Clinical Deep Dive
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Robert Spiera, MD
  Peer
Implementing Biologics into Treatment for your Lupus Patients
Medical Industry Feature
Implementing Biologics into Treatment for your Lupus Patients
- Jennifer Caudle, DO
  Peer
- Alvin F. Wells, MD, PhD
  Peer
Insights on a Treatment Option for Lupus Nephritis
Medical Industry Feature
Insights on a Treatment Option for Lupus Nephritis
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Reinaldo Rosario, MD
  Peer
Inflammation Biosimilars: Examining the Totality of Evidence for Approval
Medical Industry Feature
Inflammation Biosimilars: Examining the Totality of Evidence for Approval
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Gil Melmed, MD, MS
  Peer
Go Beyond the Symptoms: Redefining Treatment Goals for Lupus
Medical Industry Feature
Go Beyond the Symptoms: Redefining Treatment Goals for Lupus
- Paul Doghramji, MD
  Peer
- Kristi Mizelle, MD, MPH, FACR
  Peer
Examining Clinical Data for a Lupus Nephritis Treatment
Medical Industry Feature
Examining Clinical Data for a Lupus Nephritis Treatment
- Paul Doghramji, MD
  Peer
- Dawn Caster, MD
  Peer
Proteinuria in Lupus: A Biomarker of Activity & an Accelerant of Damage
Medical Industry Feature
Proteinuria in Lupus: A Biomarker of Activity & an Accelerant of Damage
- Jennifer Caudle, DO
  Peer
- Maria Dall'Era, MD
  Peer
- Tina Kochar, MD
  Peer
Future Imaging Modalities in Spondyloarthritis
Living Rheum
Future Imaging Modalities in Spondyloarthritis
- Ethan Craig, MD, MHS
  Peer
- Walter Maksymowych, MB ChB, FRCP(C), FACP
  Peer
Medical Detectives: How to Optimize the Diagnosis of Still’s Disease Patients
Living Rheum
Medical Detectives: How to Optimize the Diagnosis of Still’s Disease Patients
- Jason Liebowitz, MD
  Peer
- Bella Mehta, MBBS, MS, MD
  Peer
The Role of Imaging in Determining Treatment Escalation in Spondyloarthritis
Living Rheum
The Role of Imaging in Determining Treatment Escalation in Spondyloarthritis
- Ethan Craig, MD, MHS
  Peer
- Catherine J. Bakewell, MD
  Peer
Assessing Disease Activity in Clinical Practice: Tools to Monitor axSpA
Living Rheum
Assessing Disease Activity in Clinical Practice: Tools to Monitor axSpA
- Ethan Craig, MD, MHS
  Peer
- Dr. Lianne Gensler, MD
  Peer
Using MRI to Differentiate Axial Spondyloarthritis From Osteoarthritis
Living Rheum
Using MRI to Differentiate Axial Spondyloarthritis From Osteoarthritis
- Ethan Craig, MD, MHS
  Peer
- Walter Maksymowych, MB ChB, FRCP(C), FACP
  Peer
Imaging in the Diagnosis of Sjögren’s Disease
Living Rheum
Imaging in the Diagnosis of Sjögren’s Disease
- Ethan Craig, MD, MHS
  Peer
- Sara S. McCoy, MD, PhD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended